Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person NF1 R2637Q [cytosol]
| Class:Id | EntityWithAccessionedSequence:9647525 |
|---|---|
| _displayName | NF1 R2637Q [cytosol] |
| _timestamp | 2019-05-31 15:52:57 |
| compartment | [Compartment:70101] cytosol |
| created | [InstanceEdit:9647526] Rothfels, Karen, 2019-05-31 |
| crossReference | [DatabaseIdentifier:9647452] COSMIC:COSV62205700 |
| disease | [Disease:3310977] small intestine carcinoma |
| endCoordinate | 2839 |
| hasModifiedResidue | [ReplacedResidue:9647426] L-arginine 2637 replaced with L-glutamine |
| literatureReference | [LiteratureReference:9646931] Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients |
| name | NF1 R2637Q |
| referenceEntity | [ReferenceGeneProduct:60115] UniProt:P21359 NF1 [Homo sapiens] |
| species | [Species:48887] Homo sapiens |
| stableIdentifier | [StableIdentifier:9647527] R-HSA-9647525.1 |
| startCoordinate | 2 |
| (hasCandidate) | [CandidateSet:6802562] NF1 GTPase mutants [cytosol] [Homo sapiens] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by NF1 R2637Q [cytosol] (9647525)
